CollPlant Biotechnologies Q1 Adj $(0.35), Inline, Sales $98.00K Miss $600.00K Estimate
Portfolio Pulse from Benzinga Newsdesk
CollPlant Biotechnologies (NASDAQ:CLGN) reported Q1 losses of $(0.35) per share, meeting analyst estimates but showing a 20.69% increase in losses compared to last year. Sales were $98,000, missing the $600,000 estimate by 83.67% and down 77.37% from last year.
May 29, 2024 | 11:03 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
CollPlant Biotechnologies reported Q1 losses of $(0.35) per share, meeting analyst estimates but showing a 20.69% increase in losses compared to last year. Sales were $98,000, missing the $600,000 estimate by 83.67% and down 77.37% from last year.
The company's earnings per share met expectations, but the significant miss in sales and the year-over-year decline in both earnings and sales are likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100